AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) delivered its policy recommendations, “AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures” to Mr. Katsunobu Kato, Minister of Health, Labour and Welfare.

The meeting with Minister Kato was attended by Dr. Masaki Yoshida, President of the Japanese Society for Infection Prevention and Control and Professor of Infection Diseases and Infection Control at The Jikei University Hospital, as well as Dr. Kiyoshi Kurokawa, Chairman of HGPI, and Mr. Joji Sugawara, Senior Associate at HGPI.

AMR Alliance Japan’s Recommendations were announced on July 11, 2019, and are available to download at the bottom of this page.

[About AMR Alliance Japan]
AMR Alliance Japan was established in November 2018 as multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. Current members include, in alphabetical order: The Japanese Association for Infectious Diseases, The Japanese Society for Clinical Microbiology, The Japanese Society for Infection Prevention and Control, The Japanese Society for Medical Mycology, The Japanese Society for Pediatric Infectious Diseases, The Japanese Society of Chemotherapy, The Japanese Society of Pharmaceutical Healthcare and Sciences, The Japanese Society of Therapeutic Drug Monitoring, The Japan Pharmaceutical Manufacturers Association, MSD K.K., Nippon Becton, Dickinson and Company, Ltd., Pfizer Japan Inc., The Pharmaceutical Society of Japan, Shionogi & Co., Ltd., and Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai. The Health and Global Policy Institute (HGPI) serves as Secretariat of the Alliance.